CompletedInterventionalPhase 3Last updated Mar 7, 2012

Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

Double-blind, Placebo-controlled, Randomized, Multicentre Phase II/III Study to Evaluate the Efficacy and Safety of Lisuride, Applied Subcutaneously by Means of a Minipump in Patients With Advanced Parkinson's Disease Refractory to Conventional Oral Therapy

Overview

ClinicalTrials.gov ID: NCT00408915
Lead Sponsor: Axxonis Pharma AGINDUSTRY
Brief Summary: The aim of the study is to evaluate the long-term efficacy, local tolerability and safety of Lisuride applied as subcutaneous infusion compared to placebo in patients with advanced Parkinson's disease with motor fluctuations and "OFF" periods refractory to conventional treatment.
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Jul 2006
Primary Completion Date: No data available
Completion Date: No data available

Study Record Dates

First Submitted: Dec 5, 2006
First Submitted that Met QC Criteria: Dec 6, 2006
First Posted: Dec 7, 2006Estimated
Last Update Submitted that Met QC Criteria: Mar 6, 2012
Last Update Posted: Mar 7, 2012Estimated
Last Verified: Mar 2012

NCT00089622Completed

Lisuride Patch to Treat Parkinson's Disease

NCT02782481Withdrawn

A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

NCT04006210Active, not recruiting

Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations

NCT01883505Completed

A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients

NCT05766813Completed

Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

NCT04380142Completed

Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease